Chairman of the Montreux Healthcare Advisory Board (MHAB), Prof. Barry Carpenter has been awarded an Honorary Doctorate from Oxford Brookes University to recognise his 40-year commitment to education for children with special needs.

The doctorate recognises Prof. Carpenter’s pioneering work in the field which has contributed significantly to the advancement of special education across the UK and the world, improving educational attainment for some of the most vulnerable children in society.

On his award, Prof. Carpenter stated: “I am profoundly moved that the University has chosen to acknowledge this lifelong association, and the impact of the career they prepared me for.”

Oliver Harris, CEO, Montreux Capital Management (UK) stated: “We have been working with Prof. Carpenter for a while now and have always been struck by the awards he has amassed over the years. They recognise an invaluable contribution to his field, and we are extremely grateful for his advice and collaboration over the years.”

Find Us

Thameside House
Hurst Road
East Molesey
KT8 9AY

T: + 44 (0) 1932 860 140
E: info@montreuxcm.com

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.

ACCEPT